Impact BioMedical Inc. (NYSE American: IBO) is proud to announce our participation in the upcoming Spartan Capital Securities, LLC Investor Conference 2024 on November 4th at The Pierre Hotel, New York City. With our leadership team, including Frank D. Heuszel, Mark Suseck, and Todd Macko, CPA, we are excited to engage with conference attendees and share our latest advancements. Special thanks to our hosts at Spartan Capital for bringing together an incredible lineup of public company executives and institutional investors. For those interested in attending, you can request to participate here: https://lnkd.in/e6ZQhZyA. We look forward to seeing you there!
Impact BioMedical Inc. (NYSE American: IBO)’s Post
More Relevant Posts
-
Tomorrow marks the 4th of July, a day to celebrate America's independence and the innovative spirit that has fueled our nation. Here at BioHub Maryland, we're proud to carry that torch forward by fostering collaboration and accelerating talent in the life sciences industry. Celebrate with us by answering one of these questions in the comments below: • What scientific discovery are you most grateful for? • How do you see science shaping the future of America?
-
-
Today’s R&D isn’t a solo sport—it’s a team effort! Interdisciplinary collaboration has become essential to drive innovation and accelerate discovery. Discover the latest trends in scientific collaboration and practical strategies to help your team work smarter together. Watch the Webinar: https://hubs.ly/Q02ZBnnq0
-
-
The June edition of MERIT Insights is online now! Our latest eNewsletter includes an overview of our recent conferences, important industry news you may have missed, a video clip from MERIT's latest webinar, and much more. Read here: https://lnkd.in/ggpsEGrY #MERITCRO #YourClinicalEndpointExpert #clinicaltrials #clinicalresearch
-
-
Our expansion into the US is all about broadening horizons across the Atlantic and strengthening collaboration between the UK and the US. 🤝 The new hub will open doors to groundbreaking collaborations, drive innovative research, and foster a shared commitment to addressing global challenges. Hear from Thomas Hall, Imperial alum and Founder & CEO of Embed Biotech, as he shares his thoughts at our launch event - and his own exciting plans for expansion into the US 👇
-
The May edition of MERIT Insights is online now! Our latest eNewsletter includes an overview of our recent conferences, important industry news you may have missed, a recap of MERIT's latest webinar, and much more. Check it out: https://lnkd.in/gEdbcQ_Y #MERITCRO #YourClinicalEndpointExpert #clinicaltrials #clinicalresearch
-
-
Providing a simple platform for real world data collection and bringing transparency to patient outcomes
TOBI: The Orthobiologic Institute conference is only couple weeks away! 🎉 Check out a list of some of the upcoming DataBiologics speakers below! ✅ We’re going to be there, are you? ⁉️ #data #orthobiologics #regenerativemedicine #prp #bmac #shockwavetherapy #sportsmedicine #painmanagement #orthopedics #patientcenteredcare #clinicalresearch
We're excited for some of our contributors to be on the podium at TOBI 2024! TOBI: The Orthobiologic Institute Register here to join thought leaders in Las Vegas, NV: https://lnkd.in/gn4sxAQy
-
-
Biotech and life science conferences can bring incredible value to your organization, but involvement is a significant investment of both time and money. How can you maximize your ROI? 🤔 At Samba, we know what it takes to have a successful conference season. Not only have we attended biotech conferences, but we’ve also helped numerous clients assemble engaging booths, showcase their products and services, and host memorable networking events. We’ve created a comprehensive guide to share our recommendations for all investment levels. Are you ready to elevate your conference strategy? https://hubs.li/Q02vmnLP0 #BiotechMarketing #LifeScienceMarketing #ROI #BiotechConference #LeadGeneration
-
-
More exciting news from the RI Life Science Hub!
We are proud to announce that the board of directors has selected Mark A. Turco, M.D., F.A.C.C., to be the organization’s first President and Chief Executive Officer. Dr. Turco has more than 25 years of executive experience in advancing medical technology development, clinical medicine, academic research and innovation. “With a top-tier board, the launch of an incubator lab and other programs, and now a dynamic, experienced candidate to lead the Life Science Hub, I am confident that we will deliver on the bold vision of transforming Rhode Island into a nationally recognized center for life sciences innovation,” said Neil Steinberg, Chairman of the Board.
-